48-week of statin therapy for T2DM patients with LEAD: comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of diabetes investigation"
DOI: 10.1111/jdi.13472
Abstract: AIMS Type 2 diabetes mellitus (T2DM) is correlated with systemic atherosclerosis. Statin therapies have been proved to reduce low-density lipoprotein cholesterol (LDL-C) level, protecting T2DM patients from cardiovascular events. Recently, more interest has been focused… read more here.
Keywords: t2dm; t2dm patients; effects pitavastatin; ldl level ... See more keywords